Lantmännen has signed an agreement to acquire HKScan Corporation’s Swedish operations, HKScan Sweden AB. The acquisition includes all operations in Sweden and the brands Scan, Pärsons and Bullens. The acquisition means that Lantmännen is broadening and strengthening its business portfolio from field to fork – and that long-term conditions for Swedish agriculture are strengthened.

HKScan’s Swedish operations offers meat- and plant-based food from Swedish farms, employs about 1,800 people, and in 2022 had net sales of approximately SEK 8 billion. The Swedish business has production facilities in Kristianstad, Skara, Linköping and Halmstad – and is Swedish headquarter in Stockholm.

In connection with the acquisition, Lantmännen also transfers all its existing shares in HKScan Corporation to HKScan Corporation. The transaction is subject to approval by relevant authorities, and is expected to be completed during the first half of 2024.  

Vinge’s team consisted of Christina Kokko, Karl Klackenberg, Clara Sohlberg and Robin Sultani (M&A), Johan Cederblad (Environment), Kristoffer Larson and Alexandra Tamm (Real Estate), Trine Osen Bergqvist and Jesper Ekman (Competition law), Malin Malm Waerme and Johan Gavelin (IP), Lisa Hörnqvist (GDPR), Eva Fredriksson, Jolene Reimerson and Carla Zachariasson (IT and Commercial Agreements), Mia Falk and Julia Löfquist (Regulatory), Agnes Pigg (Employment) and Emy Rydén (Transaction Support Coordinator).

Read the client's press release

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025